EUVIMEDSkopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC 4.0

Non-human leukocyte antigen antibodies in kidney transplantation: pathogenic mechanisms, detection methods, and clinical implications

Inseong Oh iD, Eun Young Song iD

Clinical Transplantation and Research · 2025-09-30 · 39 (3) · 214-229

DOI: 10.4285/ctr.25.0057 ↗

At a glance

Übersichtsarbeit in Clinical Transplantation and Research, published on 2025-09-30. Written by Inseong Oh and 1 co-authors. Institution: Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea. Cited 6 times so far (Crossref); 85 references. The full text is freely available (open access, CC BY-NC 4.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

The importance of non-human leukocyte antigen (HLA) antibodies in transplant immunology has become increasingly evident, as their pathogenic role in kidney allograft injury is being clarified beyond the well-established effects of donor-specific anti-HLA antibodies. This review summarizes current evidence regarding antigenic targets, pathogenic mechanisms, detection platforms, and clinical implications of non-HLA antibodies in kidney transplantation. Major antigenic targets include angiotensin II type 1 receptor (AT1R), endothelin A receptor (ETAR), major histocompatibility complex class I-related chain A (MICA), vimentin, perlecan fragment LG3 (LG3), collagen, and fibronectin. These contribute to graft injury through both complement-dependent mechanisms (e.g., LG3, MICA) and complement-independent pathways, such as G protein-coupled receptor agonism by AT1R/ETAR and natural killer cell-mediated antibody-dependent cellular cytotoxicity, frequently acting together with HLA antibodies to exacerbate microvascular inflammation. Detection methods range from traditional cell-based assays to high-throughput multiplex bead arrays. However, lack of assay standardization and variability in interpretation remain major barriers to clinical implementation. Approaches such as assessing antibody burden and profiling antibody signatures using multiplex platforms show promise for enhancing immunological risk stratification, although further research and multicenter validation are required. Integrating non-HLA with HLA antibody evaluation, supported by standardized protocols and incorporation of multiomics data, may improve prognostication, guide personalized immunosuppressive strategies, and ultimately enhance kidney transplant outcomes.

Subjects

Author keywords

Graft rejectionHLA antigensKidney transplantationRisk assessment

Authors and institutions

  • Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Korea.

ORCID profiles: Inseong Oh, Eun Young Song

Cite

APA

Oh, I., & Song, E. Y. (2025). Non-human leukocyte antigen antibodies in kidney transplantation: pathogenic mechanisms, detection methods, and clinical implications. Clinical Transplantation and Research, 39(3), 214-229. https://doi.org/10.4285/ctr.25.0057

Vancouver

Oh I, Song EY. Non-human leukocyte antigen antibodies in kidney transplantation: pathogenic mechanisms, detection methods, and clinical implications. Clinical Transplantation and Research. 2025;39(3):214-229. doi:10.4285/ctr.25.0057

BibTeX
@article{Oh2025,
  author = {Oh, Inseong and Song, Eun Young},
  title = {Non-human leukocyte antigen antibodies in kidney transplantation: pathogenic mechanisms, detection methods, and clinical implications},
  journal = {Clinical Transplantation and Research},
  year = {2025},
  volume = {39},
  number = {3},
  pages = {214--229},
  doi = {10.4285/ctr.25.0057}
}
Start for free →